Skip to content
← Full study record

NCT01532687 · MORE INFO

Limitations, agreements, and source contact

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · Source last updated 2021-09-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
ryanc@ohsu.edu
organization
OHSU Knight Cancer Institute
phone
503-494-9000
title
Dr. Christopher Ryan
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
ryanc@ohsu.edu
organization
OHSU Knight Cancer Institute
phone
503-494-9000
title
Dr. Christopher Ryan

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice